Insights On CONTRACT PHARMA MANUFACTURING

  1. Precision Polymorph Screening With Electron Diffraction 5/6/2026

    See how polymorph screening with electron diffraction uncovers hidden forms, enabling precise identification and reliable quantification of minor phases affecting performance and manufacturability.

  2. De-Risking Drug Development: Informatics-Supported Solid Form Selection 5/6/2026

    Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.

  3. Mechanochemistry- Enabled Solid-State Stress Testing 5/6/2026

    Discover how solvent‑free, solid‑state stress testing speeds degradation studies, yields realistic impurity profiles, and provides earlier, material‑efficient insight into drug stability and risk.

  4. Enhancing Safety In Drug Substance Synthesis: A Smart Approach To Chemical Design 5/6/2026

    Discover how safety‑by‑design principles in chemical synthesis help control exothermic reactions, reduce scale‑up risk, and enable safer, more reliable manufacturing of complex drug substances.

  5. Chirality In Drug Development: From Racemic Mixtures To Enantiopure Substances 5/6/2026

    Chiral crystallization enables efficient production of enantiopure drug substances, improving pharmacological control and safety while supporting scalable, cost‑effective small molecule development.

  6. How To Save Significantly On Early-Phase Clinical Supply 5/6/2026

    Discover how integrated clinical supply strategies streamline early trials, reduce logistics complexity, cut costs, and ensure timely delivery of investigational products and samples.

  7. EMA Support For SMEs Through Scientific Advice And Early Dialogue 5/6/2026

    Discover how early engagement with European regulators helps smaller drug developers reduce uncertainty, clarify requirements, and de‑risk innovative programs through early dialogue.

  8. Optimising Solubility: Selecting The Right Technology For Early Drug Development 5/6/2026

    Discover how selecting the right solubility‑enhancing technology improves early exposure, supports flexible dosing, and lays a strong foundation for downstream oral drug development.

  9. Defining Acceptable Impurity Levels For Drug Substances In GLP Toxicology Studies 5/6/2026

    Uncover how aligning impurity profiles between toxicology and clinical drug substance builds translational confidence, supports regulatory readiness, and reduces late‑stage development risk.

  10. (Cross-) Contamination Control Through Effective Equipment Cleaning 5/6/2026

    Discover science-driven cleaning strategies that reduce cross-contamination, enable safe multiproduct manufacturing, and support faster, flexible GMP changeovers.